To award task order d-03: pre-clinical microbiological and safety studies; $1,698,255
Ended Awarded Last action
- Contract number
- 75N93019F00132
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,693,585
Award facts
- Opportunity
-
- NIHAI2017090 Solicitation number
- Nonclinical Services for Development of Interventional Agents for Infectious Diseases Award Notice · Posted Feb 13, 2017
- Contract value 100% obligated
- $1,693,585.40 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$4,670 | |
| Other Administrative Action | $0 | |
| Original award | $1,698,255 |
About this award
This is a cost-plus-fixed-fee delivery order awarded to SRI International, a nonprofit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The $1,693,585.40 task order is for pre-clinical microbiological and safety studies and was issued under NIAID's Nonclinical Services for Development of Interventional Agents IDIQ contract. The award does not use a small business set-aside. SRI International has expertise in biomedical research, drug discovery, and preclinical studies, and frequently performs work for HHS agencies including NIH, CDC, and FDA through prime and subcontract awards.
Quick answers
Who was awarded contract 75N93019F00132?
75N93019F00132 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2019.
How much is contract 75N93019F00132 worth?
The government has obligated $1,693,585 on 75N93019F00132.
Is contract 75N93019F00132 an order under another contract?
Yes. 75N93019F00132 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93019F00132 competed?
The extent of competition for 75N93019F00132 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award